Pigment Cell & Melanoma Research

Papers
(The TQCC of Pigment Cell & Melanoma Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
An update on Vitiligo pathogenesis61
Management of hyperpigmentation: Current treatments and emerging therapies48
Rab GTPases: Key players in melanosome biogenesis, transport, and transfer44
Chemical and biochemical control of skin pigmentation with special emphasis on mixed melanogenesis39
The evolution of human skin pigmentation involved the interactions of genetic, environmental, and cultural variables37
Nicotinamide N‐methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines33
Participation of keratinocyte‐ and fibroblast‐derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders33
Genetics of non‐syndromic and syndromic oculocutaneous albinism in human and mouse31
The α‐melanocyte‐stimulating hormone/melanocortin‐1 receptor interaction: A driver of pleiotropic effects beyond pigmentation30
Alterations of the pigmentation system in the aging process29
The role of ferroptosis in melanoma29
The fate of melanocyte: Mechanisms of cell death in vitiligo28
Strategies in DNA vaccine for melanoma cancer25
The role of technology in melanoma screening and diagnosis24
The tumour immune landscape and its implications in cutaneous melanoma23
Cyclic adenosine monophosphate (cAMP) signaling in melanocyte pigmentation and melanomagenesis22
The structure and function of the mouse tyrosinase locus22
First‐line atezolizumab monotherapy in patients with advanced BRAFV600 wild‐type melanoma22
NRF2‐dependent stress defense in tumor antioxidant control and immune evasion20
Identification of melanoma‐specific exosomal miRNAs as the potential biomarker for canine oral melanoma20
The effect of aging and antioxidants on photoreactivity and phototoxicity of human melanosomes: An in vitro study18
Support for increased cardiovascular risk in non‐segmental vitiligo among Egyptians: A hospital‐based, case–control study17
Dark cyclobutane pyrimidine dimers are formed in the epidermis of Fitzpatrick skin types I/II and VI in vivo after exposure to solar‐simulated radiation17
Artificial intelligence and melanoma: A comprehensive review of clinical, dermoscopic, and histologic applications17
A Focused review on the pathophysiology of post‐inflammatory hyperpigmentation16
The PI3K pathway induced by αMSH exerts a negative feedback on melanogenesis and contributes to the release of pigment15
Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells15
Current landscape of Oculocutaneous Albinism in Japan15
Human TYRP1: Two functions for a single gene?15
Dhh‐expressing Schwann cell precursors contribute to skin and cochlear melanocytes, but not to vestibular melanocytes15
HPS11 and OCA8: Two new types of albinism associated with mutations in BLOC1S5 and DCT genes15
The MITF regulatory network in melanoma14
The AMP‐dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma14
Altered expression of ferroptosis markers and iron metabolism reveals a potential role of ferroptosis in vitiligo13
User guide to MiT‐TFE isoforms and post‐translational modifications13
Vitiligo: Translational research and effective therapeutic strategies13
The unfolded protein and integrated stress response in melanoma and vitiligo12
Immunotherapy for older patients with melanoma: From darkness to light?12
RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological features11
Reconstructed human pigmented skin/epidermis models achieve epidermal pigmentation through melanocore transfer11
Analysis of CRISPR‐Cas9 screens identifies genetic dependencies in melanoma11
Phenotypic plasticity of melanocytes derived from human adult skin11
YAP facilitates melanoma migration through regulation of actin‐related protein 2/3 complex subunit 5 (ARPC5)11
The role of melanocytes in the human choroidal microenvironment and inflammation: Insights from the transcriptome11
A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma11
Melanin‐concentrating hormone like and somatolactin. A teleost‐specific hypothalamic‐hypophyseal axis system linking physiological and morphological pigmentation11
Genetic variants and mutational spectrum of Chinese Hermansky–Pudlak syndrome patients10
Consideration of possible effects of vitamin D on established cancer, with reference to malignant melanoma10
New insights into the pathogenesis of Hermansky–Pudlak syndrome10
Five novel mutations in SASH1 contribute to lentiginous phenotypes in Japanese families10
Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma10
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance10
Acral lentiginous melanoma—Population, treatment, and survival using the NCDB from 2004 to 20159
The delicate relation between melanocytes and skin immunity: A game of hide and seek9
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation9
Drosophila yellow‐h encodes dopaminechrome tautomerase: A new enzyme in the eumelanin biosynthetic pathway9
Transcriptomic analysis and ednrb expression in cochlear intermediate cells reveal developmental differences between inner ear and skin melanocytes9
The impaired unfolded protein‐premelanosome protein and transient receptor potential channels‐autophagy axes in apoptotic melanocytes in vitiligo9
Multiple desmoplastic Spitz nevi with BRAF fusions in a patient with ring chromosome 7 syndrome9
Eosinophils and melanoma: Implications for immunotherapy8
Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy8
Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma8
Connexins in melanoma: Potential role of Cx46 in its aggressiveness8
The feather pattern autosomal barring in chicken is strongly associated with segregation at the MC1R locus8
Antihypertensives and melanoma: An updated review8
Recurrent co‐alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis8
Volar location and degree of pigmentation are associated with poor survival and first metastasis pattern in acral melanoma7
Heme oxygenase promotes B‐Raf‐dependent melanosphere formation7
The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma7
Establishment of a mouse model for post‐inflammatory hyperpigmentation7
Systematic review and meta‐analysis of genomic alterations in acral melanoma6
Investigating DNA methylation as a potential mediator between pigmentation genes, pigmentary traits and skin cancer6
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study6
Advancements in melanoma cancer metastasis models6
Topical RT1640 treatment effectively reverses gray hair and stem cell loss in a mouse model of radiation‐induced canities6
A novel BLOC1S5‐related HPS‐11 patient and zebrafish with bloc1s5 disruption6
A B‐cell or a key player? The different roles of B‐cells and antibodies in melanoma6
0.23727917671204